je.st
news
PharmaCyte Biotech Appoints American Stock Transfer as New Stock Transfer Agent
2015-07-10 00:21:48| Biotech - Topix.net
PharmaCyte Biotech, Inc. , a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-BoxA , announced today that, effective July 10, 2015, American Stock Transfer & Trust Company will replace Signature Stock Transfer as its stock transfer and dividend disbursing agent. The Chief Executive Officer of PharmaCyte Biotech, Kenneth L. Waggoner, commented on PharmaCyte Biotech's new stock transfer agent, "We are extremely pleased to announce that we have appointed AST to be our new stock transfer agent.
Tags: american
stock
agent
transfer
Category:Biotechnology and Pharmaceuticals